Annual CFF
$493.00 K
-$161.00 K-24.62%
31 December 2023
Summary:
Athira Pharma annual cash flow from financing activities is currently $493.00 thousand, with the most recent change of -$161.00 thousand (-24.62%) on 31 December 2023. During the last 3 years, it has fallen by -$292.26 million (-99.83%). ATHA annual CFF is now -99.83% below its all-time high of $292.75 million, reached on 31 December 2020.ATHA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$12.00 K
-$136.00 K-91.89%
30 September 2024
Summary:
Athira Pharma quarterly cash flow from financing activities is currently $12.00 thousand, with the most recent change of -$136.00 thousand (-91.89%) on 30 September 2024. Over the past year, it has increased by +$12.00 thousand (+100.00%). ATHA quarterly CFF is now -99.99% below its all-time high of $184.28 million, reached on 30 September 2020.ATHA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$312.00 K
+$12.00 K+4.00%
30 September 2024
Summary:
Athira Pharma TTM cash flow from financing activities is currently $312.00 thousand, with the most recent change of +$12.00 thousand (+4.00%) on 30 September 2024. Over the past year, it has dropped by -$176.00 thousand (-36.07%). ATHA TTM CFF is now -99.92% below its all-time high of $388.12 million, reached on 31 March 2021.ATHA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.6% | +100.0% | -36.1% |
| 3 y3 years | -99.8% | -90.4% | -99.7% |
| 5 y5 years | -66.3% | - | - |
ATHA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.8% | at low | -96.0% | -99.7% | +254.6% | |
| 5 y | 5 years | -99.8% | at low | -100.0% | +104.6% | -99.9% | +254.6% |
| alltime | all time | -99.8% | at low | -100.0% | +104.6% | -99.9% | +254.6% |
Athira Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.00 K(-91.9%) | $312.00 K(+4.0%) |
| June 2024 | - | $148.00 K(>+9900.0%) | $300.00 K(-23.9%) |
| Mar 2024 | - | $0.00(-100.0%) | $394.00 K(-20.1%) |
| Dec 2023 | $493.00 K(-24.6%) | $152.00 K(>+9900.0%) | $493.00 K(+1.0%) |
| Sept 2023 | - | $0.00(-100.0%) | $488.00 K(0.0%) |
| June 2023 | - | $242.00 K(+144.4%) | $488.00 K(-10.1%) |
| Mar 2023 | - | $99.00 K(-32.7%) | $543.00 K(-17.0%) |
| Dec 2022 | $654.00 K | $147.00 K(>+9900.0%) | $654.00 K(+25.8%) |
| Sept 2022 | - | $0.00(-100.0%) | $520.00 K(-19.4%) |
| June 2022 | - | $297.00 K(+41.4%) | $645.00 K(+633.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $210.00 K(+1515.4%) | $88.00 K(-99.9%) |
| Dec 2021 | $97.09 M(-66.8%) | $13.00 K(-89.6%) | $97.09 M(-18.0%) |
| Sept 2021 | - | $125.00 K(-148.1%) | $118.40 M(-60.9%) |
| June 2021 | - | -$260.00 K(-100.3%) | $302.56 M(-22.0%) |
| Mar 2021 | - | $97.21 M(+355.9%) | $388.12 M(+32.6%) |
| Dec 2020 | $292.75 M(>+9900.0%) | $21.32 M(-88.4%) | $292.75 M(+7.9%) |
| Sept 2020 | - | $184.28 M(+116.0%) | $271.43 M(+211.5%) |
| June 2020 | - | $85.30 M(+4536.1%) | $87.14 M(+4636.1%) |
| Mar 2020 | - | $1.84 M | $1.84 M |
| Dec 2019 | $946.00 K(-35.4%) | - | - |
| Dec 2018 | $1.46 M | - | - |
FAQ
- What is Athira Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Athira Pharma?
- What is Athira Pharma annual CFF year-on-year change?
- What is Athira Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Athira Pharma?
- What is Athira Pharma quarterly CFF year-on-year change?
- What is Athira Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Athira Pharma?
- What is Athira Pharma TTM CFF year-on-year change?
What is Athira Pharma annual cash flow from financing activities?
The current annual CFF of ATHA is $493.00 K
What is the all time high annual CFF for Athira Pharma?
Athira Pharma all-time high annual cash flow from financing activities is $292.75 M
What is Athira Pharma annual CFF year-on-year change?
Over the past year, ATHA annual cash flow from financing activities has changed by -$161.00 K (-24.62%)
What is Athira Pharma quarterly cash flow from financing activities?
The current quarterly CFF of ATHA is $12.00 K
What is the all time high quarterly CFF for Athira Pharma?
Athira Pharma all-time high quarterly cash flow from financing activities is $184.28 M
What is Athira Pharma quarterly CFF year-on-year change?
Over the past year, ATHA quarterly cash flow from financing activities has changed by +$12.00 K (+100.00%)
What is Athira Pharma TTM cash flow from financing activities?
The current TTM CFF of ATHA is $312.00 K
What is the all time high TTM CFF for Athira Pharma?
Athira Pharma all-time high TTM cash flow from financing activities is $388.12 M
What is Athira Pharma TTM CFF year-on-year change?
Over the past year, ATHA TTM cash flow from financing activities has changed by -$176.00 K (-36.07%)